Skip Navigation
Skip to contents

Korean J Gastroenterol.  2014 Jun;63(6):378-381. 10.4166/kjg.2014.63.6.378.

Clinical Review and Case Report of Ceftriaxone-associated Gallbladder Pseudolithiasis in Adult

Affiliations
  • 1Department of Surgery, Yeungnam University College of Medicine, Daegu, Korea. dslee@med.yu.ac.kr

Abstract

Although ceftriaxone can be used safely in most instances, it can sometimes induce biliary sludge or stone formation. Most of the patients remain asymptomatic and children are more susceptible to develop this condition, but adults can be affected as well. Because sludge or stones disappear after discontinuing ceftriaxone, this condition is referred to as ceftriaxone-associated pseudolithiasis. A 54-year-old woman was admitted to a local clinic for management of ileus. During admission, she had received ceftriaxone and metronidazole, and had been on nil per os for the past 6 days. She was then referred to our hospital for cholecystectomy due to persistent right upper quadrant pain. Although imaging studies showed gallbladder sludge, pseudolithiasis was suspected because of ceftriaxone administration history and prolonged fasting. After careful watch-and-wait, the condition resolved spontaneously after ceftriaxone discontinuation. Our clear understanding on ceftriaxone-associated gallbladder pseudolithiasis allowed us to avoid an unnecessary cholecystectomy. Herein, we report the case of a 54-year-old woman with ceftriaxone-associated gallbladder pseudolithiasis that was successfully managed by ceftriaxone discontinuation alone.

Keyword

Ceftriaxone; Gallbladder; Pseudolithiasis

MeSH Terms

Adult
Aged
Anti-Bacterial Agents/*adverse effects
Ceftriaxone/*adverse effects
Cholecystectomy
Cholecystolithiasis/*diagnosis/epidemiology/etiology
Female
Gallbladder/ultrasonography
Humans
Male
Middle Aged
Retrospective Studies
Tomography, X-Ray Computed
Anti-Bacterial Agents
Ceftriaxone
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr